All contributors
Onconephrology contributor
Bridoux, Frank
Primarily MGRS & paraprotein kidney disease#6 of 47 recognizedHonor roll
- #4 in MGRS & paraprotein kidney disease
74
Clinical papers
4,314
Citations (iCite)
15 / 19
First / senior author
2002–2026
Active years
Output over time
Clinical corpus papers per year — peak 7 in 2021.
- 2002: 1 paper
- 2003: 1 paper
- 2005: 1 paper
- 2006: 1 paper
- 2010: 1 paper
- 2011: 6 papers
- 2012: 5 papers
- 2013: 2 papers
- 2014: 1 paper
- 2015: 5 papers
- 2016: 6 papers
- 2017: 6 papers
- 2018: 5 papers
- 2019: 4 papers
- 2020: 5 papers
- 2021: 7 papers
- 2022: 5 papers
- 2023: 4 papers
- 2024: 2 papers
- 2025: 5 papers
- 2026: 1 paper
20022026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
MGRS & paraprotein kidney disease65
Myeloma cast nephropathy44
Anticancer drug nephrotoxicity10
Cellular therapy renal effects2
Frequent collaborators
Other recognized contributors who most often share corpus papers with Bridoux (shared-paper count).
Agents they study
Catalog agents whose clinical kidney literature lists Bridoux among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.